# WW International, Inc.: financial statements, quarterly WW · Nasdaq · CIK 105319 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/ww.md) · [Financials](/companies/ww/financials.md) · [Filings](/companies/ww/filings.md) · [Insiders](/companies/ww/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ww/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-24) | Q3 FY2025 (2025-09-30) | Q2 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [215](/filings/0000950170-24-122255.md) | [206](/filings/0000950170-24-022144.md) | [207](/filings/0000950170-25-064482.md) | [202](/filings/0000950170-25-106230.md) | [193](/filings/0001193125-25-268065.md) | [184 d](/filings/0001193125-26-107176.md) | [187](/filings/0001193125-26-210307.md) | [177](/filings/0001193125-26-335166.md) | [172](/filings/0001193125-25-268065.md) | [175 d](/filings/0001193125-26-107176.md) | [168](/filings/0001193125-26-210307.md) | [162](/filings/0001193125-26-335166.md) | | Cost of revenue | $m | [73.1](/filings/0000950170-24-122255.md) | [81.1 d](/filings/0001193125-26-107176.md) | [68.7](/filings/0000950170-25-064482.md) | [64.8](/filings/0000950170-25-106230.md) | [63.4](/filings/0001193125-25-268065.md) | [55.9 d](/filings/0001193125-26-107176.md) | [53.7](/filings/0001193125-26-210307.md) | [46.5](/filings/0001193125-26-335166.md) | [48.0](/filings/0001193125-25-268065.md) | [52.0 d](/filings/0001193125-26-107176.md) | [49.6](/filings/0001193125-26-210307.md) | [48.2](/filings/0001193125-26-335166.md) | | Gross profit | $m | [142](/filings/0000950170-24-122255.md) | [125](/filings/0000950170-24-022144.md) | [138](/filings/0000950170-25-064482.md) | [137](/filings/0000950170-25-106230.md) | [129](/filings/0001193125-25-268065.md) | [129 d](/filings/0001193125-26-107176.md) | [133](/filings/0001193125-26-210307.md) | [131](/filings/0001193125-26-335166.md) | [124](/filings/0001193125-25-268065.md) | [123 d](/filings/0001193125-26-107176.md) | [119](/filings/0001193125-26-210307.md) | [114](/filings/0001193125-26-335166.md) | | Selling, general and administrative | $m | [63.0](/filings/0000950170-24-122255.md) | [28.9 d](/filings/0001193125-26-107176.md) | [59.0](/filings/0000950170-25-064482.md) | [36.9](/filings/0000950170-25-106230.md) | [57.0](/filings/0001193125-25-268065.md) | [35.2 d](/filings/0001193125-26-107176.md) | [35.6](/filings/0001193125-26-210307.md) | [42.9](/filings/0001193125-26-335166.md) | [60.1](/filings/0001193125-25-268065.md) | [55.5 d](/filings/0001193125-26-107176.md) | [48.1](/filings/0001193125-26-210307.md) | [50.4](/filings/0001193125-26-335166.md) | | Operating income | $m | [30.6](/filings/0000950170-24-122255.md) | [(6.0)](/filings/0000950170-24-022144.md) | [(269)](/filings/0000950170-25-064482.md) | [35.9](/filings/0000950170-25-106230.md) | [(39.0)](/filings/0001193125-25-268065.md) | [36.2 d](/filings/0001193125-26-107176.md) | [(20.2)](/filings/0001193125-26-210307.md) | [41.4](/filings/0001193125-26-335166.md) | [8.0](/filings/0001193125-25-268065.md) | [(10.4) d](/filings/0001193125-26-107176.md) | [(30.4)](/filings/0001193125-26-210307.md) | [9.5](/filings/0001193125-26-335166.md) | | Interest expense | $m | [24.5](/filings/0000950170-24-122255.md) | [37.4 d](/filings/0001193125-26-107176.md) | [24.7](/filings/0000950170-25-064482.md) | [28.6](/filings/0000950170-25-106230.md) | [28.6](/filings/0001193125-25-268065.md) | [28.7 d](/filings/0001193125-26-107176.md) | [28.2](/filings/0001193125-26-210307.md) | [11.1](/filings/0001193125-26-335166.md) | [12.1](/filings/0001193125-25-268065.md) | [14.9 d](/filings/0001193125-26-107176.md) | [12.2](/filings/0001193125-26-210307.md) | [12.0](/filings/0001193125-26-335166.md) | | Income tax | $m | [(38.4)](/filings/0000950170-24-122255.md) | [57.6](/filings/0000950170-24-022144.md) | [55.4](/filings/0000950170-25-064482.md) | [(15.8)](/filings/0000950170-25-106230.md) | [(27.3)](/filings/0001193125-25-268065.md) | [(11.7) d](/filings/0001193125-26-107176.md) | [22.6](/filings/0001193125-26-210307.md) | [(20.9)](/filings/0001193125-26-335166.md) | [53.2](/filings/0001193125-25-268065.md) | [(19.4) d](/filings/0001193125-26-107176.md) | [10.8](/filings/0001193125-26-210307.md) | [(11.2)](/filings/0001193125-26-335166.md) | | Net income | $m | [43.7](/filings/0000950170-24-122255.md) | [(88.1)](/filings/0000950170-24-022144.md) | [(348)](/filings/0000950170-25-064482.md) | [23.3](/filings/0000950170-25-106230.md) | [(46.2)](/filings/0001193125-25-268065.md) | [25.1 d](/filings/0001193125-26-107176.md) | [(72.6)](/filings/0001193125-26-210307.md) | [1,191](/filings/0001193125-26-335166.md) | [(57.5)](/filings/0001193125-25-268065.md) | [(4.6) d](/filings/0001193125-26-107176.md) | [(52.0)](/filings/0001193125-26-210307.md) | [14.1](/filings/0001193125-26-335166.md) | | Diluted EPS | $ per share | [0.54](/filings/0000950170-24-122255.md) | [(1.11)](/filings/0000950170-24-022144.md) | [(4.39)](/filings/0000950170-25-064482.md) | [0.29](/filings/0000950170-25-106230.md) | [(0.58)](/filings/0001193125-25-268065.md) | not reported | [(0.91)](/filings/0001193125-26-210307.md) | [14.67](/filings/0001193125-26-335166.md) | [(5.76)](/filings/0001193125-25-268065.md) | not reported | [(5.20)](/filings/0001193125-26-210307.md) | [1.41](/filings/0001193125-26-335166.md) | | Basic EPS | $ per share | [0.55](/filings/0000950170-24-122255.md) | [(1.11)](/filings/0000950170-24-022144.md) | [(4.39)](/filings/0000950170-25-064482.md) | [0.29](/filings/0000950170-25-106230.md) | [(0.58)](/filings/0001193125-25-268065.md) | not reported | [(0.91)](/filings/0001193125-26-210307.md) | [14.81](/filings/0001193125-26-335166.md) | [(5.76)](/filings/0001193125-25-268065.md) | not reported | [(5.20)](/filings/0001193125-26-210307.md) | [1.41](/filings/0001193125-26-335166.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-24) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [107](/filings/0000950170-23-058352.md) | [109](/filings/0000950170-25-029511.md) | [66.6](/filings/0000950170-24-052105.md) | [42.7](/filings/0000950170-24-088946.md) | [57.2](/filings/0000950170-24-122255.md) | [53.0](/filings/0001193125-26-107176.md) | [236](/filings/0000950170-25-064482.md) | [141](/filings/0001193125-26-107176.md) | [170](/filings/0001193125-25-268065.md) | [160](/filings/0001193125-26-335166.md) | [121](/filings/0001193125-26-210307.md) | [101](/filings/0001193125-26-335166.md) | | Current assets | $m | [219](/filings/0000950170-23-058352.md) | [179](/filings/0000950170-25-029511.md) | [117](/filings/0000950170-24-052105.md) | [88.1](/filings/0000950170-24-088946.md) | [101](/filings/0000950170-24-122255.md) | [103](/filings/0001193125-26-107176.md) | [281](/filings/0000950170-25-064482.md) | [252](/filings/0001193125-26-107176.md) | [219](/filings/0001193125-25-268065.md) | [214](/filings/0001193125-26-335166.md) | [168](/filings/0001193125-26-210307.md) | [147](/filings/0001193125-26-335166.md) | | Total assets | $m | [1,032](/filings/0000950170-23-058352.md) | [982](/filings/0000950170-25-029511.md) | [654](/filings/0000950170-24-052105.md) | [614](/filings/0000950170-24-088946.md) | [562](/filings/0000950170-24-122255.md) | [550](/filings/0001193125-26-107176.md) | [697](/filings/0000950170-25-064482.md) | [1,024](/filings/0001193125-26-107176.md) | [969](/filings/0001193125-25-268065.md) | [947](/filings/0001193125-26-335166.md) | [881](/filings/0001193125-26-210307.md) | [840](/filings/0001193125-26-335166.md) | | Current liabilities | $m | [194](/filings/0000950170-23-058352.md) | [205](/filings/0000950170-25-029511.md) | [249](/filings/0000950170-24-052105.md) | [200](/filings/0000950170-24-088946.md) | [189](/filings/0000950170-24-122255.md) | [173](/filings/0001193125-26-107176.md) | [1,822](/filings/0000950170-25-064482.md) | [133](/filings/0001193125-26-107176.md) | [133](/filings/0001193125-25-268065.md) | [127](/filings/0001193125-26-335166.md) | [141](/filings/0001193125-26-210307.md) | [106](/filings/0001193125-26-335166.md) | | Total liabilities | $m | [1,707](/filings/0000950170-23-058352.md) | [1,743](/filings/0000950170-25-029511.md) | [1,767](/filings/0000950170-24-052105.md) | [1,702](/filings/0000950170-24-088946.md) | [1,691](/filings/0000950170-24-122255.md) | [1,665](/filings/0001193125-26-107176.md) | [1,880](/filings/0000950170-25-064482.md) | [645](/filings/0001193125-26-107176.md) | [646](/filings/0001193125-25-268065.md) | [629](/filings/0001193125-26-335166.md) | [616](/filings/0001193125-26-210307.md) | [562](/filings/0001193125-26-335166.md) | | Long-term debt | $m | [1,425](/filings/0000950170-23-058352.md) | [1,426](/filings/0000950170-25-029511.md) | [1,428](/filings/0000950170-24-052105.md) | [1,429](/filings/0000950170-24-088946.md) | [1,430](/filings/0000950170-24-122255.md) | [1,431](/filings/0001193125-26-107176.md) | not reported | [466](/filings/0001193125-26-107176.md) | [465](/filings/0001193125-25-268065.md) | [465](/filings/0001193125-26-335166.md) | [439](/filings/0001193125-26-210307.md) | [424](/filings/0001193125-26-335166.md) | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | [1,603](/filings/0000950170-25-064482.md) | not reported | not reported | not reported | [26.8](/filings/0001193125-26-210307.md) | not reported | | Shareholders' equity | $m | [(675)](/filings/0000950170-24-122255.md) | [(761)](/filings/0001193125-26-107176.md) | [(1,112)](/filings/0000950170-25-106230.md) | [(1,087)](/filings/0001193125-25-268065.md) | [(1,129)](/filings/0001193125-25-268065.md) | [(1,114)](/filings/0001193125-26-335166.md) | [(1,183)](/filings/0001193125-26-335166.md) | [379](/filings/0001193125-26-335166.md) | [323](/filings/0001193125-25-268065.md) | [318](/filings/0001193125-26-335166.md) | [266](/filings/0001193125-26-335166.md) | [279](/filings/0001193125-26-335166.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-24) | Q3 FY2025 (2025-09-30) | Q2 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [25.9 d](/filings/0000950170-24-122255.md) | [7.8 d](/filings/0001193125-26-107176.md) | [(36.0)](/filings/0000950170-25-064482.md) | [(1.9) d](/filings/0000950170-25-106230.md) | [16.5 d](/filings/0001193125-25-268065.md) | [4.6 d](/filings/0001193125-26-107176.md) | [15.0](/filings/0001193125-26-210307.md) | [(49.4) d](/filings/0001193125-26-335166.md) | [8.4](/filings/0001193125-25-268065.md) | [(2.9) d](/filings/0001193125-26-107176.md) | [(33.5)](/filings/0001193125-26-210307.md) | [24.3 d](/filings/0001193125-26-335166.md) | | Capital expenditure | $m | [0.4 d](/filings/0000950170-24-122255.md) | [0.3 d](/filings/0001193125-26-107176.md) | [0.5](/filings/0000950170-25-064482.md) | [0.3 d](/filings/0000950170-25-106230.md) | [(0.1) d](/filings/0001193125-25-268065.md) | [0.1 d](/filings/0001193125-26-107176.md) | [0.0](/filings/0001193125-26-210307.md) | [0.1 d](/filings/0001193125-26-335166.md) | [0.0](/filings/0001193125-25-268065.md) | not reported | not reported | not reported | | Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: not reported - Share repurchases: not reported ## Shares | Line item | Unit | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-24) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [70.4](/filings/0000950170-23-058352.md) | [70.6](/filings/0000950170-24-052105.md) | [78.6](/filings/0000950170-24-088946.md) | [80.6](/filings/0000950170-24-122255.md) | [79.2](/filings/0000950170-25-064482.md) | [79.8](/filings/0000950170-25-106230.md) | [79.7](/filings/0001193125-25-268065.md) | [80.1](/filings/0001193125-26-210307.md) | [81.2](/filings/0001193125-26-335166.md) | [10.0](/filings/0001193125-25-268065.md) | [10.0](/filings/0001193125-26-210307.md) | [10.0](/filings/0001193125-26-335166.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 9,998,760 at 2026-07-30, from the cover of the [10-Q filed 2026-08-05](/filings/0001193125-26-335166.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.